Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Mar 13 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-13-2024-3

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 13, 2024, titled "Zydus launches IBYRA, the generic version of Olaparib, brings both access and affordability for cancer patients in India".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases